Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
39.17
+0.56 (1.45%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 38.43 - 39.47
52 week 32.11 - 51.84
Open 38.61
Vol / Avg. 96,745.00/127,841.00
Mkt cap 871.38M
P/E 51.68
Div/yield 1.00
EPS 0.76
Shares 22.25M
Beta 0.98
Inst. own 101%
Apr 24, 2014
Q4 2014 ABAXIS INC Earnings Conference Call - 4:15PM EDT - Add to calendar
Apr 24, 2014
Q4 2014 ABAXIS INC Earnings Release - 4:00PM EDT - Add to calendar
Mar 18, 2014
ABAXIS INC at Sidoti & Company's Emerging Growth Institutional Investor Forum
Mar 18, 2014
ABAXIS INC at Lazard MedTech, Diagnostics & Healthcare IT Snowbird Conference
Mar 3, 2014
ABAXIS INC at Raymond James Financial Inc Institutional Investors Conference
Jan 30, 2014
Q3 2014 ABAXIS INC Earnings Conference Call - Webcast
Jan 30, 2014
Q3 2014 ABAXIS INC Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 7.90% 14.76%
Operating margin 11.33% 22.65%
EBITD margin - 16.76%
Return on average assets 6.16% 14.32%
Return on average equity 6.96% 16.35%
Employees 535 -
CDP Score - -

Address

3240 Whipple Road
UNION CITY, CA 94587
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. The Company�s segments include the medical market and the veterinary market. The Company has developed a blood analysis system incorporating all of these criteria into a 5.1 kilogram (11.2 pounds) portable analyzer and a series of menu-specific, multi-test single-use reagent discs. Abaxis markets its blood chemistry analyzers in the medical market and in the veterinary market. The Company markets the blood analysis system in the medical market under the name Piccolo Xpress. It markets the blood analysis system in the veterinary market under the name VetScan VS2.

Officers and directors

Clinton H. Severson Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alberto R. Santa Ines Chief Financial Officer, Vice President - Finance
Age: 66
Bio & Compensation  - Reuters
Donald P. Wood Chief Operations Officer
Age: 61
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 60
Bio & Compensation  - Reuters
Vladimir E. Ostoich Ph.D. Vice President - Marketing for Pacific Rim, Vice President - Government Affairs
Age: 67
Bio & Compensation  - Reuters
Achim Henkel Managing Director of Abaxis Europe GmbH
Age: 55
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 67
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 67
Bio & Compensation  - Reuters
Henk J. Evenhuis Independent Director
Age: 70
Bio & Compensation  - Reuters